Advancing Parenteral Package Integrity Testing: Case Studies on IV Bags and Pre-Filled Syringes: Poster Presented at PDA Week 2025.

Q3 Medicine
Rob Zecchin
{"title":"Advancing Parenteral Package Integrity Testing: Case Studies on IV Bags and Pre-Filled Syringes: Poster Presented at PDA Week 2025.","authors":"Rob Zecchin","doi":"10.5731/pdajpst.2025.25429","DOIUrl":null,"url":null,"abstract":"<p><p>Ensuring the integrity of parenteral drug packaging is critical for maintaining product sterility and patient safety. This poster presents case study data on two applications of non-destructive, deterministic Container Closure Integrity Testing (CCIT) technologies: Vacuum Decay for IV bags and MicroCurrent (HVLDmc) for pre-filled syringes. The first study evaluates the effectiveness of Vacuum Decay Technology in detecting micro defects in 200 mL and 300 mL IV bags. A statistical footprint was established using thirty negative controls, followed by testing IV bags with defects ranging from 5 μm to 20 μm. Results confirm reliable detection of 20 μm leaks in both sizes, with a demonstrated sensitivity down to 10 μm at six standard deviations (LOD6SD) in 300 mL bags. The study further validates the robustness of Vacuum Decay by showing consistent leak detection across various defect locations and sample orientations. The second study assesses the repeatability of the HVLDmc technology in detecting defects in pre-filled syringes over four weeks. Weekly testing confirmed consistent identification of negative controls, while all positive controls were detected in the first two weeks. In weeks three and four, two positive samples were not detected, possibly due to defect variability or clogging effects. These findings highlight the robustness of HVLDmc while emphasizing the need to understand defect characteristics and influencing factors. Key Takeaways: Gain a deeper Understanding the role of two technologies in parenteral packaging integrity testing. Effectiveness of Vacuum Decay for IV Bags • Vacuum Decay Technology reliably detects leaks as small as 10 μm in 300 mL IV bags with a statistical confidence level (LOD6SD). • Leak detection is consistent across various defect locations (bag body and ports) and sample orientations within the test chamber. • Demonstrates non-destructive and deterministic testing for IV bag integrity. Repeatability of HVLD MicroCurrent for Pre-Filled Syringes • HVLDmc provides a reliable method for leak detection in pre-filled syringes over a multi-week study. Practical Implications for Parenteral Drug Manufacturers • The importance of repeatability studies in CCIT to ensure robustness and reliability. • Considerations for sample preparation and defect consistency when implementing these technologies. • Reinforces compliance with regulatory expectations for deterministic, non-destructive integrity testing.</p>","PeriodicalId":19986,"journal":{"name":"PDA Journal of Pharmaceutical Science and Technology","volume":"79 4","pages":"480-481"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PDA Journal of Pharmaceutical Science and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5731/pdajpst.2025.25429","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Ensuring the integrity of parenteral drug packaging is critical for maintaining product sterility and patient safety. This poster presents case study data on two applications of non-destructive, deterministic Container Closure Integrity Testing (CCIT) technologies: Vacuum Decay for IV bags and MicroCurrent (HVLDmc) for pre-filled syringes. The first study evaluates the effectiveness of Vacuum Decay Technology in detecting micro defects in 200 mL and 300 mL IV bags. A statistical footprint was established using thirty negative controls, followed by testing IV bags with defects ranging from 5 μm to 20 μm. Results confirm reliable detection of 20 μm leaks in both sizes, with a demonstrated sensitivity down to 10 μm at six standard deviations (LOD6SD) in 300 mL bags. The study further validates the robustness of Vacuum Decay by showing consistent leak detection across various defect locations and sample orientations. The second study assesses the repeatability of the HVLDmc technology in detecting defects in pre-filled syringes over four weeks. Weekly testing confirmed consistent identification of negative controls, while all positive controls were detected in the first two weeks. In weeks three and four, two positive samples were not detected, possibly due to defect variability or clogging effects. These findings highlight the robustness of HVLDmc while emphasizing the need to understand defect characteristics and influencing factors. Key Takeaways: Gain a deeper Understanding the role of two technologies in parenteral packaging integrity testing. Effectiveness of Vacuum Decay for IV Bags • Vacuum Decay Technology reliably detects leaks as small as 10 μm in 300 mL IV bags with a statistical confidence level (LOD6SD). • Leak detection is consistent across various defect locations (bag body and ports) and sample orientations within the test chamber. • Demonstrates non-destructive and deterministic testing for IV bag integrity. Repeatability of HVLD MicroCurrent for Pre-Filled Syringes • HVLDmc provides a reliable method for leak detection in pre-filled syringes over a multi-week study. Practical Implications for Parenteral Drug Manufacturers • The importance of repeatability studies in CCIT to ensure robustness and reliability. • Considerations for sample preparation and defect consistency when implementing these technologies. • Reinforces compliance with regulatory expectations for deterministic, non-destructive integrity testing.

推进肠外包装完整性测试:静脉注射袋和预填充注射器的案例研究:2025年PDA周的海报。
确保肠外药物包装的完整性对于保持产品无菌性和患者安全至关重要。这张海报展示了两种非破坏性、确定性容器封闭完整性测试(CCIT)技术应用的案例研究数据:静脉输液袋的真空衰减和预填充注射器的微电流(HVLDmc)。第一项研究评估了真空衰减技术在检测200 mL和300 mL IV袋微缺陷中的有效性。使用30个阴性对照建立统计足迹,然后测试缺陷范围为5 μm至20 μm的静脉注射袋。结果证实了两种尺寸的20 μm泄漏的可靠检测,在300 mL的袋子中,在6个标准偏差(LOD6SD)下的灵敏度低至10 μm。该研究通过在不同缺陷位置和样品方向上显示一致的泄漏检测,进一步验证了真空衰减的鲁棒性。第二项研究评估了HVLDmc技术在4周内检测预充注射器缺陷的可重复性。每周检测确认了阴性对照的一致鉴定,而所有阳性对照均在前两周检测到。在第三周和第四周,没有检测到两个阳性样本,可能是由于缺陷可变性或堵塞效应。这些发现突出了HVLDmc的稳健性,同时强调了了解缺陷特征和影响因素的必要性。关键要点:深入了解两种技术在肠外包装完整性测试中的作用。真空衰减技术可靠地检测泄漏小至10 μm在300毫升静脉袋统计置信水平(LOD6SD)。•泄漏检测在测试室内的不同缺陷位置(袋体和端口)和样品方向上是一致的。演示静脉输液袋完整性的非破坏性和确定性测试。HVLDmc为预充式注射器的泄漏检测提供了一种可靠的方法。•CCIT中可重复性研究的重要性,以确保稳健性和可靠性。在实施这些技术时,对样品制备和缺陷一致性的考虑。•加强符合法规对确定性、非破坏性完整性测试的期望。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.90
自引率
0.00%
发文量
34
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信